Jan Schjøtt

1.6k total citations · 1 hit paper
91 papers, 1.2k citations indexed

About

Jan Schjøtt is a scholar working on Geriatrics and Gerontology, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jan Schjøtt has authored 91 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Geriatrics and Gerontology, 16 papers in Public Health, Environmental and Occupational Health and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jan Schjøtt's work include Pharmaceutical Practices and Patient Outcomes (19 papers), Pregnancy and Medication Impact (12 papers) and Cardiac Ischemia and Reperfusion (9 papers). Jan Schjøtt is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (19 papers), Pregnancy and Medication Impact (12 papers) and Cardiac Ischemia and Reperfusion (9 papers). Jan Schjøtt collaborates with scholars based in Norway, Denmark and Sweden. Jan Schjøtt's co-authors include Tormod Bjånes, Emmet McCormack, Spiros Kotopoulis, Odd Helge Gilja, Bjørn Tore Gjertsen, Anders Molven, Halfdan Sørbye, Dag Hoem, Georg Dimcevski and Michiel Postema and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jan Schjøtt

82 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer

2016 359 citations Georg Dimcevski, Spiros Kotopoulis et al. Journal of Controlled Release profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Schjøtt Norway	19	357	166	165	153	147	91	1.2k
Nguyen D Nguyen Australia	31	111 0.3×	55 0.3×	221 1.3×	207 1.4×	161 1.1×	51	3.0k
Steven M. Belknap United States	22	51 0.1×	116 0.7×	73 0.4×	367 2.4×	79 0.5×	60	2.4k
Theresa P. Devasia United States	14	168 0.5×	38 0.2×	198 1.2×	118 0.8×	63 0.4×	23	2.4k
Stéphane Sanchez France	18	66 0.2×	80 0.5×	124 0.8×	57 0.4×	17 0.1×	138	1.0k
Eric J. F. Franssen Netherlands	25	110 0.3×	113 0.7×	92 0.6×	81 0.5×	27 0.2×	114	2.1k
Joseph Bubalo United States	20	103 0.3×	67 0.4×	122 0.7×	18 0.1×	36 0.2×	64	1.4k
Sandhiya Selvarajan India	17	101 0.3×	62 0.4×	81 0.5×	51 0.3×	69 0.5×	80	1.0k
Maria Shubina United States	20	70 0.2×	124 0.7×	113 0.7×	280 1.8×	16 0.1×	43	1.8k
Shengming Liu China	21	66 0.2×	24 0.1×	96 0.6×	54 0.4×	101 0.7×	69	1.6k
Qian Yu China	19	155 0.4×	27 0.2×	78 0.5×	27 0.2×	39 0.3×	68	1.5k

Countries citing papers authored by Jan Schjøtt

Since Specialization

Citations

This map shows the geographic impact of Jan Schjøtt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Schjøtt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Schjøtt more than expected).

Fields of papers citing papers by Jan Schjøtt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Schjøtt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Schjøtt. The network helps show where Jan Schjøtt may publish in the future.

Co-authorship network of co-authors of Jan Schjøtt

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Schjøtt. A scholar is included among the top collaborators of Jan Schjøtt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Schjøtt. Jan Schjøtt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garcia, Beate Hennie, et al.. (2024). Exploring virtual delivery of academic detailing to general practitioners compared with in-person delivery: a qualitative study. BMJ Open Quality. 13(4). e002444–e002444. 1 indexed citations

Schjøtt, Jan, et al.. (2023). Self‐perceived learning outcomes of virtual and in‐person academic detailing among general practitioners in Norway. Basic & Clinical Pharmacology & Toxicology. 134(2). 284–289. 3 indexed citations

Schjøtt, Jan, Heather Allore, Bjørn Bendz, et al.. (2023). Sex differences in incidence of self-reported adverse drug reactions after percutaneous coronary intervention. European Heart Journal. 44(Supplement_2).

Eikrem, Øystein, Spiros Kotopoulis, Mihaela Popa, et al.. (2021). Ultrasound and Microbubbles Enhance Uptake of Doxorubicin in Murine Kidneys. Pharmaceutics. 13(12). 2038–2038. 4 indexed citations

Norekvål, Tone M, Heather Allore, Bjørn Bendz, et al.. (2020). Rethinking rehabilitation after percutaneous coronary intervention: a protocol of a multicentre cohort study on continuity of care, health literacy, adherence and costs at all care levels (the CONCARD ^PCI ). BMJ Open. 10(2). e031995–e031995. 21 indexed citations

Heitmann, Kristine & Jan Schjøtt. (2020). SafeMotherMedicine: Aiming to Increase Women’s Empowerment in Use of Medications During Pregnancy and Breastfeeding. Maternal and Child Health Journal. 24(5). 531–536. 7 indexed citations

Schjøtt, Jan, et al.. (2020). Review of Questions Concerning Clinical Drug Interactions in ADHD Treatment From Physicians in Norway. Frontiers in Pharmacology. 11. 607915–607915. 1 indexed citations

Schjøtt, Jan, et al.. (2020). Perception of prescribing factors and purchase statistics of non-steroidal anti-inflammatory drugs in an orthopedic clinic. BMC Research Notes. 13(1). 100–100. 1 indexed citations

Schjøtt, Jan, Heather Allore, Bjørn Bendz, et al.. (2019). Abstract 12227: Patients’ Perceptions of Generic Drugs After Percutaneous Coronary Intervention: A Multicentre Cohort Study. Circulation. 1 indexed citations

10.

Rekeland, Ingrid G., Øystein Fluge, Kine Alme, et al.. (2018). Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome. Clinical Therapeutics. 41(5). 806–814. 3 indexed citations

11.

Schjøtt, Jan, et al.. (2017). Shortage of Digitoxin and Switching to Digoxin in Norway: A Retrospective Study of Blood Samples Submitted to a Clinical Pharmacology Laboratory. Basic & Clinical Pharmacology & Toxicology. 121(1). 74–77. 1 indexed citations

12.

Schjøtt, Jan. (2017). Physicians’ questions concerning drug use among older patients: experience from Norwegian drug information centres (RELIS) in the period 2010–2015. Aging Clinical and Experimental Research. 30(7). 867–870. 5 indexed citations

13.

Dimcevski, Georg, Spiros Kotopoulis, Tormod Bjånes, et al.. (2016). A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. Journal of Controlled Release. 243. 172–181. 359 indexed citations breakdown →

14.

Larsen, Terje H., et al.. (2014). Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat. BMC Pharmacology and Toxicology. 15(1). 28–28. 16 indexed citations

15.

Larsen, Terje H., et al.. (2014). Morphine Enhances Doxorubicin-Induced Cardiotoxicity in the Rat. Cardiovascular Toxicology. 14(3). 251–259. 9 indexed citations

16.

Raknes, Guttorm & Jan Schjøtt. (2008). Dosering av legemidler ved overvekt og undervekt. Tidsskrift for Den Norske Laegeforening. 1 indexed citations

17.

Viktil, Kirsten K., et al.. (2001). Polypharmacy among patients admitted to hospital with rheumatic diseases.. Pharmacy World & Science. 23(4). 153–158. 20 indexed citations

18.

Schjøtt, Jan, et al.. (1995). Preconditioning by brief ischaemic episodes in the isolated rat heart assessed by³¹P NMR spectroscopy: dissociation between metabolic and functional recovery?. Scandinavian Journal of Clinical and Laboratory Investigation. 55(1). 67–78. 9 indexed citations

19.

Schjøtt, Jan, et al.. (1994). Ischaemic episodes of less than 5 minutes produce preconditioning but not stunning in the isolated rat heart. Acta Physiologica Scandinavica. 150(3). 281–291. 10 indexed citations

20.

Jones, Richard A., Olav Haraldseth, Jan Schjøtt, et al.. (1993). Effect of Gd‐DTPA‐BMA on magnetization transfer: Application to rapid imaging of cardiac ischemia. Journal of Magnetic Resonance Imaging. 3(1). 31–39. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact